NCT04647500View on ClinicalTrials.gov

Effects of Methylphenidate on Brain and Cognition in 22q11 Deletion Syndrome

NACompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

August 26, 2016

Primary Completion Date

September 26, 2022

Study Completion Date

September 26, 2022

Conditions
22q11.2 Deletion Syndrome
Interventions
DRUG

Concerta

Evaluation of a treatment of Concerta over a period of 13 days.

Trial Locations (1)

1204

Developmental imaging and psychopathology lab, Geneva

All Listed Sponsors
lead

University of Geneva, Switzerland

OTHER

NCT04647500 - Effects of Methylphenidate on Brain and Cognition in 22q11 Deletion Syndrome | Biotech Hunter | Biotech Hunter